← All trials
NCT04212078
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 29, 2019
- Primary completion
- May 31, 2020
- Completion date
- Oct 31, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 138
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- National University of MalaysiaLead sponsor
- National University of MalaysiaReponsible party - principal investigator
- Santen Inc.Collaborator
- UKM Medical CentreStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.